EXICURE, INC. Interest Expense
EXICURE, INC. (XCUR) reported Interest Expense of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-06-06
- EXICURE, INC. interest expense for the quarter ending 2023-12-31 was $0.00.
- EXICURE, INC. interest expense for the quarter ending 2023-09-30 was $0.00.
- EXICURE, INC. interest expense for the quarter ending 2023-06-30 was $0.00.
- EXICURE, INC. interest expense for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- EXICURE, INC. interest expense for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- EXICURE, INC. interest expense for fiscal 2022 was $595.00K, a 64.81% decline from fiscal 2021.
- EXICURE, INC. interest expense for fiscal 2021 was $1.69M, a 195.11% increase from fiscal 2020.
- EXICURE, INC. interest expense for fiscal 2020 was $573.00K, a 27.10% decline from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 10-K · filed 2024-06-06 |
| 2023-09-30 | $0.00 10-Q · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 10-Q · filed 2024-05-16 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-06-30 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2023-03-31 | $0.00 10-Q/A · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $0.00 derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $0.00 derived: sum of 3 quarters · filed 2024-06-06 | $595.00K 10-K · filed 2024-06-06 |
| 2022-09-30 | $0.00 10-Q · filed 2024-05-16 | $0.00 derived: sum of 2 quarters · filed 2024-06-06 | $595.00K 10-Q · filed 2024-05-16 | $972.00K derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | $0.00 10-Q/A · filed 2024-06-06 | $595.00K 10-Q/A · filed 2024-06-06 | $972.00K derived: sum of 3 quarters · filed 2024-06-06 | $1.43M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | $595.00K 10-Q/A · filed 2024-06-06 | $972.00K derived: sum of 2 quarters · filed 2024-06-06 | $1.43M derived: sum of 3 quarters · filed 2024-06-06 | $1.88M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $832.00K derived: sum of 2 quarters · filed 2023-03-27 | $1.28M derived: sum of 3 quarters · filed 2023-03-27 | $1.69M 10-K · filed 2023-03-27 |
| 2021-09-30 | $455.00K 10-Q · filed 2022-11-14 | $905.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.31M 10-Q · filed 2022-11-14 | $1.73M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $450.00K 10-Q · filed 2022-08-15 | $859.00K 10-Q · filed 2022-08-15 | $1.28M derived: sum of 3 quarters · filed 2022-08-15 | $1.30M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $409.00K 10-Q · filed 2022-05-16 | $827.00K derived: sum of 2 quarters · filed 2022-05-16 | $854.00K derived: sum of 3 quarters · filed 2022-05-16 | $854.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $445.00K derived: sum of 2 quarters · filed 2022-03-25 | $445.00K derived: sum of 3 quarters · filed 2022-03-25 | $573.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $27.00K 10-Q · filed 2021-11-19 | $27.00K derived: sum of 2 quarters · filed 2021-11-19 | $155.00K 10-Q · filed 2021-11-19 | $352.00K derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $128.00K 10-Q · filed 2021-08-12 | $325.00K derived: sum of 3 quarters · filed 2021-08-12 | $528.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $128.00K 10-Q · filed 2021-05-12 | $325.00K derived: sum of 2 quarters · filed 2021-05-12 | $528.00K derived: sum of 3 quarters · filed 2021-05-12 | $731.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $400.00K derived: sum of 2 quarters · filed 2021-03-11 | $603.00K derived: sum of 3 quarters · filed 2021-03-11 | $786.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $203.00K 10-Q · filed 2020-11-12 | $406.00K derived: sum of 2 quarters · filed 2020-11-12 | $589.00K 10-Q · filed 2020-11-12 | $764.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $203.00K 10-Q · filed 2020-08-12 | $386.00K 10-Q · filed 2020-08-12 | $561.00K derived: sum of 3 quarters · filed 2020-08-12 | $731.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $183.00K 10-Q · filed 2020-05-14 | $358.00K derived: sum of 2 quarters · filed 2020-05-14 | $528.00K derived: sum of 3 quarters · filed 2020-05-14 | $694.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $345.00K derived: sum of 2 quarters · filed 2020-03-10 | $511.00K derived: sum of 3 quarters · filed 2020-03-10 | $672.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | $170.00K 10-Q · filed 2019-11-07 | $336.00K derived: sum of 2 quarters · filed 2019-11-07 | $497.00K 10-Q · filed 2019-11-07 | $676.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $166.00K 10-Q · filed 2019-08-08 | $327.00K 10-Q · filed 2019-08-08 | $506.00K derived: sum of 3 quarters · filed 2019-09-23 | $707.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | $161.00K 10-Q · filed 2019-05-08 | $340.00K derived: sum of 2 quarters · filed 2019-09-23 | $541.00K derived: sum of 3 quarters · filed 2019-09-23 | |
| 2017-12-31 | $179.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | $380.00K derived: sum of 2 quarters · filed 2019-09-23 | $795.00K 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | $201.00K 10-Q · filed 2018-11-06 | $616.00K 10-Q · filed 2018-11-06 | ||
| 2017-08-31 | $377.00 10-Q · filed 2017-09-12 | $592.00 10-Q · filed 2017-09-12 | ||
| 2017-06-30 | $211.00K 10-Q · filed 2018-08-06 | $415.00K 10-Q · filed 2018-08-06 | ||
| 2017-05-31 | $215.00 10-Q · filed 2017-07-11 | |||
| 2017-03-31 | $204.00K 10-Q · filed 2018-05-15 | $412.00K derived: sum of 2 quarters · filed 2018-05-15 | $620.00K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $416.00K derived: sum of 2 quarters · filed 2018-03-09 | $724.00K 10-K · filed 2018-03-09 | |
| 2016-09-30 | $208.00K 10-Q · filed 2017-11-14 | $516.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |